Cardiovascular disease after renal transplantation

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 158-165

  Kasiske, Bertram L ^a,b   Guijarro, Carlos ^a   Massy, Ziad A ^a   Wiederkehr, Michael R ^a   Ma, Jennie Z ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Cerebrovascular disease; Coronary heart disease; Graft rejection; Hyperlipidemia; Peripheral vascular disease

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; FEMALE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030042245     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v71158     Document Type: Article

References (30)

1. United States Renal Data System. USRDS 1994; Annual Data Report. Bethesda, MD: The National Institutes of Health: National Institute of Diabetes and Digestive and Kidney Diseases; 1994.
2. Heule H, Keusch G, Uhlschmid G, Largiader F, Binswanger U: Kardiovasculäre Krankheiten nach Nierentransplantation: Eine Analyse prädisponierender Facktoren. Schweiz Med Wochenschr 1981;20:709-716.
3. Lemmers MJ, Barry JM: Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients. Diabetes Care 1991;14:295-301.
4. Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JLCM.: Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 1994;57:73-81.
5. Abdulmassih Z, Chevalier A, Bader C, Drücke T, Kreis H, Lacour B: Role of lipid disturbances in the atherosclerosis of renal transplant patients. Clin Transplant 1992; 6:106-113.
6. Massy ZA, Millet P, Helenon O, et al.: Ultrasonographically assessed carotid plaques: Relation with cardiovascular risk factors in renal transplant recipients [Abstract]. J Am Soc Nephrol 1993;4:948A.
7. Adams HP Jr, Dawson G, Coffman TJ, Cony RJ: Stroke in renal transplant recipients. Arch Neurol 1986;43:113-115.
8. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA: Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 1993;7:523-527.
9. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988;84:985-992.
10. Rubin DB, Schenker N: Multiple imputation in healthcare databases: An overview and some applications. Stat Med 1991;10:585-598.
11. Norusis MJ. Statistical Package for the Social Sciences (SPSS/PC+ V2.0): Base Manual. Chicago: SPSS Inc.; 1988.
12. Dixon WJ, Brown MB, Engelman L, et al. Statistics: BMDP Statistical Software. Berkeley: University of California Press; 1985.
13. Jung K, Neumann R, Scholz D, Nugel E: Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients. Clin Nephrol 1982;17:191-194.
14. Tall AR: Plasma high density lipoproteins: Metabolism and relationship to atherogenesis. J Clin Invest 1990;86: 379-384.
15. Lamarche B, Després J-P, Pouliot M-C, et al.: Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 1993;13:33-40.
16. Boudreaux JP, McHugh L, Canafax DM, et al.: The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987;44:376-381.
17. Friedman EA, Shyh T, Beyer MM, Manis T, Butt KMH: Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985;5:196-202.
18. Reaven GF, Hoffman BB: A role for insulin in the aetiology and course of hypertension? Lancet 1987;2:435-437.
19. Ferrannini E, Natali A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991;121:1274-1282.
20. Hall JE: Hyperinsulinemia: A link between obesity and hypertension? Kidney Int 1993;43:1402-1417.
21. Soper WBXIV: Zür Physiologie des Cholesterinstoffwechsels. VI. Über Beziehungen der Milz Zum Cholesterinstoffwechsel. Beitr Pathol 1915;1:232-244.
22. Aviram M, Brook JG, Tatarsky I, Levy Y, Carter A: Increased low-density lipoprotein levels after splenectomy: A role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 1986;291: 25-28.
23. Robinette CD, Fraumeni JF Jr: Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet 1977;2:127-129.
24. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
25. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-119.
26. Phillips A, Shaper AG, Whincup PH: Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;2:1434-1436.
27. Gillum RF, Ingram DD, Makuc DM: Relation between serum albumin concentration and stroke incidence and death: The NHANES I epidemiologic follow-up study. Am J Epidemiol 1994;140:876-888.
28. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP: The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1991;134:1266-1277.
29. Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986;29: 282-286.
30. Kasiske BL: Atherosclerosis in organ transplant recipients. In: Paul LC, Solez K, Eds. Organ Transplantation: Long-Term Results. New York: Marcel Dekker, Inc.; 1992:283-301.